The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1

Roberto R. Rosato, Jorge A. Almenara, Steven Grant

Research output: Contribution to journalArticlepeer-review

411 Scopus citations

Fingerprint Dive into the research topics of 'The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21<sup>CIP1/WAF1</sup>'. Together they form a unique fingerprint.

Medicine & Life Sciences